Literature DB >> 3157395

Cellular immunity in congestive cardiomyopathy. The normal cellular immune response.

P J Lowry, R A Thompson, W A Littler.   

Abstract

In vivo and in vitro tests of cellular immunity were studied in patients with congestive cardiomyopathy to determine whether these patients have normal or depressed cell mediated immunity to common environmental antigens and mitogens. No abnormality was found, but this does not exclude the possibility that transient depression of cell mediated mechanisms occurs early in the illness before clinical presentation.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3157395      PMCID： PMC481779          DOI： 10.1136/hrt.53.4.394

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  25 in total

Review 1.  Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.

Authors:  J R David; R R David
Journal:  Prog Allergy       Date:  1972

2.  Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.

Authors:  J F Woodruff; J J Woodruff
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

3.  Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease.

Authors:  C Kawai
Journal:  Jpn Circ J       Date:  1971-07

Review 4.  The cardiomyopathies.

Authors:  J F Goodwin; C M Oakley
Journal:  Br Heart J       Date:  1972-06

5.  Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population.

Authors:  D L Palmer; W P Reed
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

6.  Autoimmune studies in patients with primary myocardial disease.

Authors:  G F Fletcher; N K Wenger
Journal:  Circulation       Date:  1968-06       Impact factor: 29.690

7.  An in vitro assay for cellular hypersensitivity in man.

Authors:  R E Rocklin; O L Meyers; J R David
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

8.  Residual pathologic changes following murine coxsackie A and B myocarditis.

Authors:  F M Wilson; Q R Miranda; J L Chason; A M Lerner
Journal:  Am J Pathol       Date:  1969-05       Impact factor: 4.307

9.  "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation.

Authors:  D C Dumonde; R A Wolstencroft; G S Panayi; M Matthew; J Morley; W T Howson
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

10.  Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422
View more
  4 in total

1.  The authors reply.

Authors:  P J Lowry; M D Gammage; R A Thompson; W A Littler
Journal:  Br Heart J       Date:  1988-02

2.  Dilated cardiomyopathy, myocarditis, and the bioptome.

Authors:  P J Lowry; M D Gammage; W A Littler
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

3.  Suppressor T lymphocyte function in patients with idiopathic congestive cardiomyopathy.

Authors:  P J Lowry; M D Gammage; T A Gentle; M I Baynham; R A Thompson; W A Littler
Journal:  Br Heart J       Date:  1987-05

4.  Cellular immunity in congestive cardiomyopathy. Hypersensitivity to cardiac antigens.

Authors:  P J Lowry; R A Thompson; W A Littler
Journal:  Br Heart J       Date:  1985-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.